Post-Induction Adalimumab Concentration is Associated with Short-Term Mucosal Healing in Patients with Ulcerative Colitis.
about
Utilisation of anti-TNF levels in a UK tertiary IBD centre.Therapeutic Drug Monitoring During Induction of Anti-Tumor Necrosis Factor Therapy in Inflammatory Bowel Disease: Defining a Therapeutic Drug Window.Adalimumab in ulcerative colitis - efficacy, safety and optimization in the era of treat-to target.Overview of Therapeutic Drug Monitoring of Biologic Agents in Patients With Inflammatory Bowel Disease.A Survey Study of Gastroenterologists' Attitudes and Barriers Toward Therapeutic Drug Monitoring of Anti-TNF Therapy in Inflammatory Bowel Disease.Out-of-Pocket Cost Is a Barrier to Therapeutic Drug Monitoring in Inflammatory Bowel Disease.Infliximab trough concentrations during maintenance therapy are associated with endoscopic and histologic healing in ulcerative colitis.Response to Reinink.Improved Long-term Outcomes of Patients With Inflammatory Bowel Disease Receiving Proactive Compared With Reactive Monitoring of Serum Concentrations of Infliximab.Therapeutic Drug Monitoring in IBD: The New Standard-of-Care for Anti-TNF Therapy.Subtherapeutic concentrations of infliximab and adalimumab are associated with increased disease activity in Crohn's disease.
P2860
Q38608944-B94FD0C4-D8E0-4EB8-B8A1-01363CF8B25FQ38620415-4D536B5F-46C6-4A9C-A0EB-E7AB58F4C6F3Q38895960-F752D1C8-AA70-403B-8FD2-A3BFB6DD4754Q42374439-E338069E-1668-453B-8B6C-1F6828835644Q47258474-019F0FC6-4450-41DF-98F6-259B7E4D8B68Q47625039-A001DDF3-DAE6-47CA-8EB4-06C082138EAAQ48170302-DAE4DC07-1FB1-4DEE-9542-1468616563D1Q50034028-F6D99160-11F6-4241-8CF6-916A6016CDD9Q50759070-12E0186D-55E4-453A-9B5B-4BAA9A524CFEQ54028296-F3FEDB95-8C5C-4C53-B59C-457E13057932Q55432449-C3AD3B10-0D3F-42E2-9C6F-B867DDEA992D
P2860
Post-Induction Adalimumab Concentration is Associated with Short-Term Mucosal Healing in Patients with Ulcerative Colitis.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Post-Induction Adalimumab Conc ...... ients with Ulcerative Colitis.
@en
Post-Induction Adalimumab Conc ...... ients with Ulcerative Colitis.
@nl
type
label
Post-Induction Adalimumab Conc ...... ients with Ulcerative Colitis.
@en
Post-Induction Adalimumab Conc ...... ients with Ulcerative Colitis.
@nl
prefLabel
Post-Induction Adalimumab Conc ...... ients with Ulcerative Colitis.
@en
Post-Induction Adalimumab Conc ...... ients with Ulcerative Colitis.
@nl
P2093
P2860
P356
P1476
Post-Induction Adalimumab Conc ...... ients with Ulcerative Colitis.
@en
P2093
Filip Baert
Konstantinos Papamichael
Marc Ferrante
Severine Vermeire
Sophie Tops
P2860
P356
10.1093/ECCO-JCC/JJW122
P577
2016-07-11T00:00:00Z